Platelet monoamine oxidase (MAO) activity and serum thyroxine indices were determined in 62 children and adolescents currently undergoing medical treatment for various thyroid disorders. The platelet MAO activity of these patients was similar to that of control and contrast groups previously reported, and there were no differences when patients were grouped according to specific thyroid disorders. Estimated free thyroxine and total thyroxine levels were generally in the upper normal or slightly elevated range and were not significantly related to MAO activity.
Monoamine oxidase (MAO) is a critical enzyme in the degradation of catecholamines and serotonin, and its function at the extremes of the usual range of activity in platelets has been associated with psychiatric disorders in childhood (Young et al. 1980 ) and adulthood (Wyatt, Potkin, and Murphy 1979) . Thyroid disease has a profound effect on the function of the nervous system (Sokoloff 1977) , and thyroid hormone exerts a regulatory effect on MAO activity in several animal tissues (Skillen, Thienes, and Strain 1961; Ho-Van-Hap, Babineau, and Berlinguet 1967; Tong and D'lorio 1976) . This regulation may occur, in part, through facilitating effects of thyroid hormone on the synthesis and stability of flavoprotein enzymes such as MAO (Rivlin 1974) .
The nature of the association between thyroid function and MAO activity differs according to the sex, age, tissue, species, and the substrate used when determining MAO activity (Skillen, Thienes, and Strain 1961; Ho-Van-Hap, Babineau, and Berlinguet 1967; Tong and DTorio 1976; Young et al. 1980) . There appear to be separate thyroid hormone effects on the two isoenzymes, Type A MAO and Type B MAO (Tong and D'lorio 1976; Cawthon and Breakefield 1979) .
There have been few studies of MAO activity in human tissues during active thyroid disease. Among the relevant findings reported are the following: Adult hyperthyroid patients had increased urinary excretion of 5-hydroxyindoleacetic acid (5-HIAA), the major serotonin metabolite, with a subsequent decrease when the patients were rendered euthyroid (Skanse and Hanson 1962; Kljatschko and Stoilow 1970) ; hypothyroid patients had normal (Haverback, Sjoerdsma, and Terry 1956) or decreased (Kljatschko and Stoilow 1970) urinary 5-HIAA. MAO activity in jejunal mucosa from hyperthyroid patients was decreased, while jejunal MAO activity from hypothyroid patients was increased (Levine et al. 1962) . While elevated serum serotonin has been reported in hyperthyroidism (Kljatschko and Stoilow 1970) , another study failed to find an abnormal serum serotonin concentration in a hyperthyroid population or altered platelet MAO activity in either hyperthyroid or hypothyroid patients (Feldman and Roche 1977) .
We have studied the effects of development on a series of Reprint requests should be sent to Dr. J.G. Young at the Child Study Center, 333 Cedar St., New Haven, CT 06510. biogenic amines and related compounds (Young et al., in press ); both platelet MAO activity (Young et al. 1980 ) and estimated free thyroxine in the serum (Young et al. 1982b ) decline in males during childhood and adolescence, suggesting that thyroid hormone might have a regulatory effect on the development of the activity of this flavoprotein enzyme. There was no clear relation between platelet MAO activity and thyroxine indices in either a population of children and adolescents with psychiatric disorders or a control group . Both of these populations had normal thyroid function. Since an observable functional interaction between thyroid hormone and MAO activity might occur only when thyroid function is outside the normal range, we investigated the relation between thyroid hormone and platelet MAO activity in young patients with thyroid disorders who were being treated with appropriate medications. If thyroid hormone has a significant regulatory effect on platelet MAO activity, it might be most visible in states of insufficient or excessive thyroid function, secondary to either underlying disease or the pharmacological treatment employed.
Subjects and Methods
Subjects were 62 children and adolescents (19 males, 43 females) being treated in the pediatric endocrinology clinic at Yale-New Haven Hospital. They ranged in age from 3.9 years to 22.5 years. All but six were taking medication, including desiccated thyroid (15), levothyroxine (26), propylthiouracil (9), methimazole (2), and several others. Functional diagnoses were primary hypothyroidism, congenital or acquired (13); secondary hypothyroidism, with hypothalamic or pituitary dysfunction (10); hyperthyroidism (19); euthyroid thyromegaly, thyroiditis (17); and simple goiter (3). Patients with a simple goiter were grouped separately from other patients with euthyroid thyromegaly who also had thyroiditis, as indicated above. Thyroiditis was determined to be present if a patient had positive circulating antibodies, either by microsomal complement fixation or hemagglutination antithyroglobulin techniques. Platelet MAO activities and serum thyroxine indices have been reported separately for a normal control group and for children and adolescents with psychiatric disorders (Young et al. 1982a) .
MAO activity was assayed using a previously described method (Roth, Young, and Cohen 1976) and serum thyroxine indices were determined in the Clinical Chemistry Laboratory of Yale-New Haven Hospital using a competitive protein binding technique (Seligson and Seligson 1972, 1978) . Thyroxine (T4, ji.g/100 ml) and residual thyroxine binding capacity (TBC, /xg/100 ml) were measured and the following derived values were also reported: total thyroxine binding capacity (TTBC, /xg/100 ml), percent thyroxine saturation of TTBC (%TS), and estimated free thyroxine (EFT, ng/100 ml). Normal ranges for these indices in this laboratory are as follows: T4 = 4.6-9.2 Mg/100 ml; TBC = 16.8-25.7 Mg/100 ml; TTBC = 22.9-36.7 Mg/100 ml; %TS = 16.0-35.0 percent; EFT = 1.0-2.1 ng/100 ml.
Results
Platelet MAO activity differs in males and females (Young et al. 1980) , so results are presented separately. The mean MAO activity did not differ from activity in control and contrast groups reported elsewhere (Young et al. 1980 ) (tables 1 and 2). There were no significant differences in platelet MAO activity among the diagnostic groups. Free and total serum T4 levels were generally in the upper normal or slightly elevated range in the diagnostic groups, and binding levels were not unusual (tables 1 and 2).
With one exception, there were no significant correlations between individual T4 indices and platelet MAO activity (table 3) . There was a negative correlation between MAO activity and residual T4 binding capacity in the male primary hypothyroid group (r = -.88, p< .05). Grouping the patient population by the medication used, and assessing group means and the relation between platelet MAO activity and individual T4 indices did not yield any significant findings.
Discussion
Altered thyroid function did not bear any consistent relation to platelet MAO activity in this group of young patients undergoing medical treatment for thyroid disorders. The corresponding correlations in female control subjects differed. In female control groups there was a negative relation between platelet MAO activity and total T4, a moderately strong negative relation between platelet MAO activity and residual T4 binding capacity, and a trend to- 2.4± 1.1 30.6 ± 4.8 13.6 ± 5.2 7.7 ± 2.8
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1.8 ± 0.8 25.1 ± 5.8 Table 2 ward a positive relation between platelet MAO activity and estimated free Tt ; these associations were either absent or weakly present in patients with thyroid disorders. The female hyperthyroid group looked particularly different from the control group in these relations between platelet MAO activity and serum T4 indices. The male patient groups were small, and there were no remarkable findings. An earlier study investigated platelet MAO activity in hyperthyroid and hypothyroid patients who were symptomatic and characterized by laboratory measures of thyroid function outside the normal range. Most were not taking medication, and those who were being treated were reported to be receiving a medication that was said not to affect platelet MAO activity (propranolol). There was no alteration of platelet MAO activity in either of these patient groups (Levine et al. 1962 ). Thyroid hormone is necessary for the synthesis of flavoprotein enzymes, such as MAO, as it enhances the conversion of riboflavin to the two flavin coenzymes, flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) (Rivlin 1974) . Thyroid hormone also stabilizes these flavoprotein enzymes, decreasing the rate at which they are degraded (Rivlin 1974) . This role in stabilization is analogous to the action of glucocorticoids in stabilizing both dopamine-j8-hydroxylase and phenylethanol N-methyltransferase, diminishing the rate of their degradation (Ciaranello 1978 ). This appears to be a general biological mechanism for the regulation of enzyme activity and further strategies should be considered in investigating thyroid-MAO interactions in humans.
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